Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FOCL
11201
CALL
EDAP TMS S.A.
FOCL
$178M
| $112K | ﹤0.01% |
16,500
-11,600
| -41% | -$80.4K |
|
11202
US Global Investors
GROW
$39.4M
| $112K | ﹤0.01% |
25,490
+4,475
| +21% | +$21.8K |
|
11203
CALL
Hudbay
HBM
$11.9B
| $112K | ﹤0.01% |
27,500
-7,700
| -22% | -$46K |
|
11204
Lightpath Technologies
LPTH
$953M
| $112K | ﹤0.01% |
90,446
+38,316
| +74% | +$60.1K |
|
11205
PUT
Liquidia Corp
LQDA
$6.66B
| $112K | ﹤0.01% |
+25,600
| New | +$132K |
|
11206
PUT
Spok Holdings
SPOK
$229M
| $112K | ﹤0.01% |
17,800
-10,200
| -36% | -$74.2K |
|
11207
PUT
Kartoon Studios
TOON
$37.4M
| $112K | ﹤0.01% |
14,820
-10,210
| -41% | -$78.1K |
|
11208
PUT
Vanda Pharmaceuticals
VNDA
$316M
| $112K | ﹤0.01% |
10,300
-1,300
| -11% | -$13.5K |
|
11209
PUT
Full Truck Alliance
YMM
$9.14B
| $112K | ﹤0.01% |
12,400
-19,300
| -61% | -$131K |
|
|
BKEP
11210
PUT
DELISTED
Blueknight Energy Partners L.P.
BKEP
| $112K | ﹤0.01% |
24,700
-54,600
| -69% | -$232K |
|
11211
PUT
Arbe Robotics
ARBE
$97.8M
| $111K | ﹤0.01% |
+20,100
| New | +$137K |
|
|
MRIN
11212
CALL
DELISTED
Marin Software
MRIN
| $111K | ﹤0.01% |
11,233
-7,617
| -40% | -$97.3K |
|
|
PGRWU
11213
DELISTED
Progress Acquisition Corp. Units
PGRWU
| $111K | ﹤0.01% |
11,235
-1,898
| -14% | -$18.8K |
|
|
UPH
11214
CALL
DELISTED
UpHealth, Inc.
UPH
| $111K | ﹤0.01% |
18,770
+2,300
| +14% | +$17.9K |
|
|
AMPE
11215
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $111K | ﹤0.01% |
2,210
+2,137
| +2,927% | +$159K |
|
|
CFRX
11216
PUT
DELISTED
ContraFect Corporation
CFRX
| $111K | ﹤0.01% |
+453
| New | +$128K |
|
|
DOYU
11217
CALL
DouYu International Holdings
DOYU
$142M
| $110K | ﹤0.01% |
9,190
+3,030
| +49% | +$46.4K |
|
11218
Gaotu Techedu
GOTU
$401M
| $110K | ﹤0.01% |
56,246
+22,465
| +67% | +$36K |
|
11219
HF Foods Group
HFFG
$99.2M
| $110K | ﹤0.01% |
21,039
-54,330
| -72% | -$304K |
|
|
REVG
11220
DELISTED
REV Group
REVG
| $110K | ﹤0.01% |
+10,124
| New | +$120K |
|
|
ORKA
11221
Oruka Therapeutics
ORKA
$7.35B
| $110K | ﹤0.01% |
3,669
-809
| -18% | -$22.9K |
|
|
VVNT
11222
CALL
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
| $110K | ﹤0.01% |
31,500
-4,900
| -13% | -$26.1K |
|
11223
CALL
Acacia Research
ACTG
$448M
| $109K | ﹤0.01% |
21,700
+3,300
| +18% | +$15.1K |
|
11224
Cyngn
CYN
$16M
| $109K | ﹤0.01% |
+7
| New | +$203K |
|
11225
CALL
SurgePays
SURG
$7.08M
| $109K | ﹤0.01% |
+22,600
| New | +$95.3K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.